FDA approves revolutionary VIZZ drops: how they will restore clarity of vision for presbyopia

The U.S. Food and Drug Administration (FDA) has approved VIZZ eye drops to improve near vision in adults suffering from presbyopia. This new medication promises relief for over 100 million Americans.

According to LENZ, VIZZ contains acetylcholine, which enhances the quality of near vision and has no side effects. The drops are applied once a day and help improve vision without glasses for up to 10 hours.

'This FDA approval is a significant step forward for LENZ and will change treatment approaches for millions of adults with near vision problems,' said LENZ Therapeutics president If Shimmelpenningk.

The mechanism of action of VIZZ involves gentle constriction of the pupil, creating a clear focus effect on nearby objects without affecting distance vision. The drug is distinct from other drops as it does not cause the 'near effect' and does not lead to blurriness.

It's worth noting that VIZZ will be the first acetylcholine-based medication available for treating presbyopia, providing a wide range of effects on near vision without side effects.